PROVENTIL HFA
SABA MDI
Albuterol sulfate · Merck (formerly Schering-Plough)
Active Medication & Mechanism
- Albuterol sulfate SABA90 mcg albuterol per actuation
Short-acting beta2-adrenergic agonist. Rapid bronchodilator via beta2-receptor stimulation on airway smooth muscle.
FDA-Approved Dosing by Indication
// approval varies by strength + age Asthma
1/1 approved regimens| Strength | Population | Dose & Frequency | Total Daily | Status |
|---|---|---|---|---|
| 90 mcg | Patients ≥4 years | 2 inhalations every 4–6 hours as needed Treatment or prevention of bronchospasm in patients with reversible obstructive airway disease. | As needed | FDA Approved |
- 90 mcg FDA ApprovedPop · Patients ≥4 years2 inhalations every 4–6 hours as neededTreatment or prevention of bronchospasm in patients with reversible obstructive airway disease.Total · As needed
Exercise-Induced Bronchospasm
1/1 approved regimens| Strength | Population | Dose & Frequency | Total Daily | Status |
|---|---|---|---|---|
| 90 mcg | Patients ≥4 years | 2 inhalations 15–30 minutes before exercise Prevention of exercise-induced bronchospasm. | As needed | FDA Approved |
- 90 mcg FDA ApprovedPop · Patients ≥4 years2 inhalations 15–30 minutes before exercisePrevention of exercise-induced bronchospasm.Total · As needed